GPX4 and cancer: In several other cancers, the downregulation of GPX4 expression was likewise observed subsequent to the introduction of exogenous copper.[57, 129, 130] These results suggest that the combination of copper ionophores, copper salts, or copper nanomaterials with ferroptosis inducers (broadly speaking, antioxidant scavengers) may become a potential strategy for cancer treatment.